scispace - formally typeset
Open AccessJournal ArticleDOI

Review article: gut flora and inflammatory bowel disease.

Reads0
Chats0
TLDR
The modifications in the various regional ecosystems in the gastrointestinal tract during inflammatory bowel disease are summarized and the possibility of modifying the ecosystem using prebiotics or probiotics offers hope for new treatment developments, particularly in the prevention of relapse.
Abstract
The pathogenesis of inflammatory bowel disease involves interactions between the host susceptibility, mucosal immunity and intestinal microflora. There is therefore great interest in the changes in the endogenous flora in inflammatory bowel disease patients and in the establishment of potential genetic variations in host responses to endogenous bacteria. In this review, we summarize the modifications in the various regional ecosystems in the gastrointestinal tract during inflammatory bowel disease (luminal bacteria in faeces or inside the gastrointestinal tract, bacteria in mucus and bacteria directly attached to the mucosa). Results were obtained following a 'candidate microorganism strategy' and, as is occurring increasingly frequently, following a 'full description strategy', which has progressed largely due to the development of culture-independent techniques. The possibility of modifying the ecosystem using prebiotics or probiotics offers hope for new treatment developments, particularly in the prevention of relapse.

read more

Citations
More filters
Journal ArticleDOI

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives

TL;DR: This dysbiosis is not characterised by lack of butyrate producing-bacteria as observed in CD but suggests a role for microorganisms with mucin degradation capacity.
Journal ArticleDOI

Towards the human intestinal microbiota phylogenetic core

TL;DR: Despite the species richness and a high individual specificity, a limited number of OTUs is shared among individuals and might represent the phylogenetic core of the human intestinal microbiota and its role in human health deserves further study.
Journal ArticleDOI

Specificities of the fecal microbiota in inflammatory bowel disease

TL;DR: In IBD the dominant fecal microbiota comprises unusual bacterial species and harbor specific discrepancies and differ from that of IC and healthy subjects.
Journal ArticleDOI

Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.

TL;DR: Future studies to further define mechanisms by which defensins and other host factors regulate the composition of the intestinal microbiota will likely provide new insights into intestinal homeostasis and new therapeutic strategies for inflammatory and infectious diseases of the bowel.
References
More filters
Journal ArticleDOI

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

TL;DR: Oral administration of a probiotic preparation containing 5 x 10 per gram of viable lyophilized bacteria of 4 strains of lactobacilli, 3 strains of bifidobacteria, and 1 strain of Streptococcus salivarius subsp.
Journal ArticleDOI

Temperature Gradient Gel Electrophoresis Analysis of 16S rRNA from Human Fecal Samples Reveals Stable and Host-Specific Communities of Active Bacteria

TL;DR: The results indicate that the combination of cloning and TGGE analysis of 16S rDNA amplicons is a reliable approach to monitoring different microbial communities in feces.
Journal ArticleDOI

Mucosal flora in inflammatory bowel disease

TL;DR: It is hypothesized that the healthy mucosa is capable of holding back fecal bacteria and that this function is profoundly disturbed in patients with IBD, suggesting that the changes in the mucosal flora in IBD are not secondary to inflammation, but a result of a specific host response.
Journal ArticleDOI

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

TL;DR: The results suggest that treatment with a non-pathogenic E. coli has an equivalent effect to mesalazine in maintaining remission of ulcerative colitis.
Journal ArticleDOI

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

TL;DR: Treatment with VSL#3 is effective in the prevention of the onset of acute pouchitis and improves quality of life of patients with ileal pouch-anal anastomosis.
Related Papers (5)